gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE American · VNRXHealthcareDiagnostics

VolitionRx Limited (VNRX)

$0.1930−8.14%
Close Nov 3, 2026 · split-adjusted
Nov 3, 2026$0.19▼ 97.80% in range
Nov 3, 2025Low $0.17 · High $54.48Nov 3, 2026
What changed · written from our data
As of Nov 3, 2026

VolitionRx Limited closed at $0.19 on Nov 3, down 8.14%, 99.6% below its 52-week closing high. Volume of 850.5K shares was 0.73× its 20-day average (below normal).

Split-adjusted performance: -16.8% over one month, -91.7% over six months, -97.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $398.66K, down 2.0% from a year earlier, with a net margin of -1953.1%.

Short interest was 1.1M shares at the Oct 15 settlement, down 4.3% from the prior report (5.1% of float, 1.0 days to cover).

Market cap$5.8M30.1M shares
Revenue · quarter$398.7K−2.0% YoY
Diluted EPS$-0.85—
P/E · TTM—P/S 2.4×
Net margin-1,953.1%Gross 100.0%
Dividend yieldNone
52-week range0.17 – 54.48−99.6% from high
Volume850.5K0.73× 20-day avg
Volatility · 60d117.6%Annualised
Short % of float5.1%1.0 days to cover
Net cash-$8.3MCash $2.8M
Next earnings—Not scheduled
Split-adjusted performance
1W +4.3%1M −16.8%3M −75.7%6M −91.7%YTD −96.2%1Y −97.8%3Y −98.8%5Y −99.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Diagnostics

Percentile among 15 companies (100 = best)

6-month momentum0
Revenue growth50
Net margin25
Value (low P/E)—
Size14

Industry medians: 6-month return +15.3%, revenue growth −2.0%, net margin −26.0%, P/E 44.8×.

Short interest

Details →
Shares short1.1M−4.3% vs prior
Days to cover1.0Settled Oct 15
% of float5.1%
Short vol. 10d54.4%of daily volume

Closest peers by size in Diagnostics

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
VNRXVolitionRx Limited$0.1930−8.14%−91.7%−2.0%−1953.1%—$5.8M
CDIOCardio Diagnostics Holdings$1.60−4.19%−12.6%−28.3%−28012.5%—$4.7MCompare
BMRABIOMERICA$1.70−1.73%−22.2%−8.3%−97.4%—$7.8MCompare
QCLSQ/C Technologies$0.4250+1.19%−88.8%———$3.5MCompare
IMDXInsight Molecular Diagnostics$2.74−4.20%−40.2%−53.9%−4711.3%—$89.7MCompare
ICCCImmucell$10.25−2.94%+15.3%+11.5%25.5%118.2$93.1MCompare
TKNOAlpha Teknova$7.34+4.71%+96.3%+18.5%−26.0%—$452.9MCompare
MYGNMyriad Genetics$6.04+3.25%+20.1%−10.5%−22.7%—$577.7MCompare
ACHVAchieve Life Sciences$6.73+1.82%+47.6%———$693.9MCompare

News about VolitionRx Limited

All news →
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable MarketsBenzinga · May 27, 2026▲ Positive

Quick answers

What does VolitionRx Limited do?
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present.
What is VNRX's market cap?
$5.80M, based on the Nov 3 close of $0.19.
Does VolitionRx Limited pay a dividend?
No regular cash dividend has been paid in the last year.
How much of VNRX is sold short?
1.1M shares, 5.1% of float, as of Oct 15, 2026.
What sector is VNRX in?
Healthcare, in the Diagnostics industry.

About VolitionRx Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

HQ: Henderson, NV75 employeesListed Apr 25, 2007volition.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology